---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-054952"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T05:13:16.502014+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Incannex Healthcare forms 50:50 JV with Mind Medicine Australia for psychedelic therapy clinic

## Summary
- JV creates 'Mind Medicine Australia Clinics' to operate a clinic in Melbourne.
- JV aims to reduce treatment costs and more than triple patient capacity for PTSD and depression.
- Patient intake expected to begin shortly in response to strong early demand.
- MMA led 2023 regulatory rescheduling of psilocybin and MDMA for clinical use in Australia.
- Incannex CEO cites alignment with long-term shareholder value and commercialization model.

## SEC filing metadata
- accession: 0001213900-25-054952
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390025054952/0001213900-25-054952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390025054952/ea0245972-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-054952
- JSON: https://secwatch.observer/filing/0001213900-25-054952.json
- Plain text: https://secwatch.observer/filing/0001213900-25-054952.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.